PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch

Cancer Sci. 2022 Jul;113(7):2472-2476. doi: 10.1111/cas.15380. Epub 2022 May 31.

Abstract

Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A-rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A-MLLT3-rearranged acute monocytic leukemia, but 6 months thereafter, relapsed as KMT2A-MLLT3-rearranged acute lymphocytic leukemia. Whole exome sequencing of the bone marrow obtained pre-post lineage switch revealed two somatic mutations of PAX5 in the relapse sample. These two PAX5 alterations were suggested to be loss of function, thus to have played the driver role in the lineage switch from acute monocytic leukemia to acute lymphocytic leukemia.

Keywords: KMT2A rearrangement; PAX5; infant leukemia; lineage switch; whole exome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow
  • Child
  • Female
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Infant
  • Leukemia, Monocytic, Acute* / genetics
  • Leukemia, Myeloid, Acute* / genetics
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • PAX5 Transcription Factor
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Recurrence

Substances

  • KMT2A protein, human
  • PAX5 Transcription Factor
  • PAX5 protein, human
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase